Second Glaucoma Drainage Devices in Refractory Pediatric Glaucoma: Failure by Fibrovascular Ingrowth - 13/06/14

Abstract |
Purpose |
To evaluate initial glaucoma drainage device failure and subsequent glaucoma drainage device placement for refractory pediatric glaucoma.
Design |
Retrospective interventional case series.
Methods |
The Duke University surgical records from a single surgeon from 1997 to 2012 were reviewed for patients having at least 2 glaucoma drainage devices for refractory pediatric glaucoma. Data collected included glaucoma diagnosis, age at surgery, surgical interventions, preoperative/postoperative IOP and medications, and complications. Failure was defined as having an IOP >21 mm Hg (or clinically inadequate), and/or IOP-reducing surgery/devastating complication.
Results |
Forty-three eyes (37 patients) had 2 or more glaucoma drainage devices. Mean age at second glaucoma drainage device implantation was 9.2 ±7.1 years, with mean IOP 30 ±11 mm Hg, on 3 ± 1 IOP-lowering medications. Fibrovascular ingrowth was documented during second glaucoma drainage device surgery in 12 of 43 eyes (28%), occurring only in Ahmed devices, at a mean of 70 months (range 11–153) after initial implantation. Failure of the second glaucoma drainage device surgery occurred in 18 of 43 eyes (42%) at mean 26.1 ± 32.2 months (median 19.3 months). Surgical success of second glaucoma drainage devices (Kaplan-Meier analysis) at 1 year, 2 years, and 3 years was 81%, 62%, and 50%, respectively.
Conclusions |
Single glaucoma drainage device surgery fails to control IOP in some eyes with refractory pediatric glaucoma. Second glaucoma drainage device implantation offers a treatment option with modest success over time. Fibrovascular ingrowth should be suspected as a relatively common cause of IOP elevation and failure after Ahmed device implantation.
Le texte complet de cet article est disponible en PDF.Plan
| Dr Tung is currently located at the Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch in Galveston, Texas. |
|
| Dr Marcus is currently located at the Virginia Eye Institute in Richmond, Virginia. |
|
| Dr Thiamthat is currently located at the Department of Ophthalmology, Lerdsin Hospital, Medical Bureau, Ministry of Public Health in Bangkok, Thailand. |
Vol 158 - N° 1
P. 113-117 - juillet 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
